How VA Rates Prostate Cancer Under DC 7528
The VA rates prostate cancer under Diagnostic Code 7528 (malignant neoplasms of the genitourinary system), assigning a 100% disability rating during any period of active treatment — including surgery, radiation therapy, hormone therapy, chemotherapy, or a combination of these. The ICD-10 code for prostate cancer is C61. Once active treatment ends, VA schedules a re-evaluation exam and rates any remaining symptoms as post-treatment residuals.
Prostate cancer is one of the most common cancers among male veterans. For veterans with qualifying Agent Orange exposure or exposure to other toxic substances covered by the PACT Act, prostate cancer is a presumptive service-connected condition — meaning you do not need to prove a nexus between your cancer and your military service. The VA simply requires proof of exposure and a current diagnosis.
Agent Orange and PACT Act: Presumptive Service Connection
Prostate cancer has been on VA's Agent Orange presumptive list since 2001. Veterans who served in:
- Vietnam between January 9, 1962, and May 7, 1975 (including offshore service under the Blue Water Navy Veterans Act)
- Korea in the demilitarized zone between September 1, 1967, and August 31, 1971
- Other locations where Agent Orange or tactical herbicides were tested or stored
...are presumed to have been exposed to Agent Orange and receive automatic service connection for prostate cancer upon diagnosis. No nexus letter is required. Visit our PACT Act Explained page to understand how the 2022 PACT Act extended presumptive coverage to additional veterans, including those exposed to burn pits and other environmental hazards in Southwest Asia.
The 100% Rating During Active Treatment
As long as you are actively receiving treatment for prostate cancer, VA maintains your rating at 100%. Active treatment includes:
- Radical prostatectomy (surgical removal of the prostate)
- External beam radiation therapy (EBRT)
- Brachytherapy (internal radiation seed implants)
- Androgen deprivation therapy (ADT) / hormone therapy
- Chemotherapy for castration-resistant prostate cancer
- Active surveillance with active monitoring interventions
The 100% rating generates a 2026 monthly compensation of $3,737.85 for a veteran with no dependents. With dependents, the amount is higher — a veteran with a spouse and two children receives $4,285.04 per month at the 100% rate in 2026.
Post-Treatment Rating: Rating Residuals After Cancer Treatment
After active treatment ends, VA schedules a new C&P exam — typically six months after treatment completion. VA then rates your ongoing disability based on residual symptoms. Common prostate cancer treatment residuals and their diagnostic codes are:
Urinary Incontinence — DC 7542
Radical prostatectomy commonly causes stress urinary incontinence. VA rates urinary incontinence under DC 7542 based on frequency and severity.
- 20% — voiding dysfunction that requires wearing absorbent materials (pads) that must be changed two to four times daily
- 40% — voiding dysfunction requiring the use of an appliance (catheter or external collection device)
- 60% — urinary retention requiring intermittent or continuous catheterization
Visit our Urinary Incontinence VA Rating page for a full breakdown of DC 7542 ratings and evidence requirements.
Obstructive Voiding Symptoms
Radiation therapy can cause radiation cystitis — inflammation and scarring of the bladder that leads to urinary frequency, urgency, and obstructive symptoms. These are also rated under DC 7542 or DC 7516 (cystitis, chronic) based on functional impairment.
Erectile Dysfunction — Special Monthly Compensation (SMC-K)
Erectile dysfunction (ED) resulting from prostatectomy, radiation, or hormone therapy is not rated under the standard rating schedule — VA cannot assign a standard percentage for ED. Instead, veterans who develop service-connected ED receive Special Monthly Compensation at the K rate (SMC-K), which pays an additional $128.89 per month in 2026 on top of your regular disability rating. SMC-K is available for any veteran with service-connected loss of use of a creative organ, and ED caused by prostate cancer treatment qualifies.
PSA Monitoring and When VA Rates Residuals
VA does not immediately drop you from 100% when your initial treatment ends if your oncologist continues active PSA monitoring with periodic treatment interventions. However, once VA determines you are in a surveillance-only phase with no active treatment occurring, the 100% rating ends and VA rates residuals. Key points about PSA monitoring and VA ratings:
- Rising PSA after prostatectomy (biochemical recurrence) that triggers secondary treatment (salvage radiation, hormone therapy) restores the 100% rating
- Stable PSA with no treatment in progress triggers a transition to residual ratings
- If residuals from prostatectomy and radiation produce combined ratings of 40% or more, TDIU may be available to maintain compensation at the 100% level
Maintaining Total Disability Post-Treatment
After prostate cancer treatment, some veterans achieve a combined rating of 100% through their residuals alone. A veteran with:
- 60% urinary incontinence (DC 7542)
- Plus additional service-connected conditions at 30–40%
...may reach 100% combined without needing to rely on the cancer rating at all. Others qualify for TDIU (Total Disability Based on Individual Unemployability) under 38 CFR § 4.16 if residuals prevent substantially gainful employment. A veteran with at least one condition rated at 60% can qualify for TDIU even without a 100% combined rating.
Documenting Your Prostate Cancer Claim
Build a complete evidence package before filing or appealing:
- Pathology report confirming prostate cancer diagnosis (Gleason score, stage, grade)
- Treatment records from urology or oncology documenting each treatment phase
- PSA history showing pre-treatment and post-treatment levels
- Records of all residual symptoms — incontinence pads used per day, ED treatment, voiding difficulty
- For Agent Orange presumptive: DD-214 showing Vietnam or qualifying service, or ship records from VA's online Blue Water Navy ship list
- For PACT Act: deployment records showing qualifying service in Southwest Asia or other covered locations
Key Takeaways
- DC 7528 provides an automatic 100% rating during any period of active prostate cancer treatment, paying $3,737.85 per month in 2026 for a veteran with no dependents.
- Prostate cancer is a presumptive condition for Agent Orange and PACT Act qualifying veterans — no nexus letter required.
- Post-treatment residuals — urinary incontinence (DC 7542) and SMC-K for erectile dysfunction ($128.89/month in 2026) — can maintain significant compensation after treatment ends.
- TDIU is available if residuals prevent substantially gainful employment, even when the combined rating falls below 100%.
Use the VA Disability Rating Calculator to estimate your combined rating from prostate cancer residuals. Learn more on the main VA Disability hub.